Avanos Medical, Inc. (NYSE:AVNS) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. lowered its position in shares of Avanos Medical, Inc. (NYSE:AVNS) by 1.9% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 75,688 shares of the company’s stock after selling 1,497 shares during the quarter. Victory Capital Management Inc. owned about 0.16% of Avanos Medical worth $1,819,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. The Manufacturers Life Insurance Company grew its position in Avanos Medical by 3.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 17,137 shares of the company’s stock worth $341,000 after purchasing an additional 590 shares during the period. New York State Teachers Retirement System grew its stake in shares of Avanos Medical by 2.0% during the 3rd quarter. New York State Teachers Retirement System now owns 72,294 shares of the company’s stock worth $1,737,000 after purchasing an additional 1,388 shares during the period. State Board of Administration of Florida Retirement System increased its holdings in shares of Avanos Medical by 8.6% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 19,053 shares of the company’s stock valued at $379,000 after purchasing an additional 1,516 shares in the last quarter. Caxton Associates LP lifted its stake in shares of Avanos Medical by 13.6% in the 2nd quarter. Caxton Associates LP now owns 17,035 shares of the company’s stock valued at $339,000 after purchasing an additional 2,034 shares during the period. Finally, Azzad Asset Management Inc. ADV grew its position in Avanos Medical by 8.5% during the second quarter. Azzad Asset Management Inc. ADV now owns 28,521 shares of the company’s stock valued at $568,000 after buying an additional 2,223 shares during the period. Hedge funds and other institutional investors own 95.17% of the company’s stock.

Avanos Medical Price Performance

Avanos Medical stock opened at $18.60 on Monday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The company’s fifty day moving average price is $21.73 and its 200 day moving average price is $21.54. The stock has a market capitalization of $854.86 million, a P/E ratio of 54.71 and a beta of 0.92. Avanos Medical, Inc. has a 1 year low of $17.39 and a 1 year high of $25.36.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.